These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 2473576)

  • 1. [Value of sonographically controlled ascites puncture in patients with advanced ovarian cancers].
    Giers H; Winterroth A; Rabsilber S
    Z Arztl Fortbild (Jena); 1989; 83(9):459-61. PubMed ID: 2473576
    [No Abstract]   [Full Text] [Related]  

  • 2. [After-care and palliative therapeutic measures in ovarian carcinoma].
    Kurz C; Vavra N; Sevelda P
    Wien Med Wochenschr; 1996; 146(1-2):34-7. PubMed ID: 8835493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term semi-permanent catheter use for the palliation of malignant ascites.
    Brooks RA; Herzog TJ
    Gynecol Oncol; 2006 May; 101(2):360-2. PubMed ID: 16499957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Palliative and nursing measures in advanced ovarian cancer].
    Schnürch HG; Bender HG
    Gynakologe; 1986 Sep; 19(3):186-93. PubMed ID: 2429901
    [No Abstract]   [Full Text] [Related]  

  • 5. [Methods of symptom control in malignant ascites].
    Bodisch A; Muschitz C; Karthaus M
    Wien Med Wochenschr; 2008; 158(23-24):687-94. PubMed ID: 19165448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Palliative approaches to the patient with breast cancer.
    Bartus CM; Schreiber JS; Kurtzman SH
    Surg Oncol Clin N Am; 2004 Jul; 13(3):517-30, ix. PubMed ID: 15236733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of the necessary total protein substitution requirements in patients with advanced stage ovarian cancer and ascites, undergoing debulking surgery. Correlation with plasma proteins.
    Vorgias G; Iavazzo C; Mavromatis J; Leontara J; Katsoulis M; Kalinoglou N; Akrivos T
    Ann Surg Oncol; 2007 Jun; 14(6):1919-23. PubMed ID: 17406944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraoperative placement of a self-retaining Foley catheter for continuous drainage of malignant ascites.
    Kuruvilla A; Busby G; Ramsewak S
    Eur J Gynaecol Oncol; 2002; 23(1):68-9. PubMed ID: 11876397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Palliative chemotherapy "near the end-of-life" in ovarian cancer: not necessarily "aggressive cure-oriented therapy".
    Markman M
    Gynecol Oncol; 2006 May; 101(2):198-9. PubMed ID: 16476472
    [No Abstract]   [Full Text] [Related]  

  • 10. Therapy for recurrent ovarian cancer.
    Kuhn WC
    Curr Womens Health Rep; 2003 Feb; 3(1):33-8. PubMed ID: 12521548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapy refractory ascites: insertion of a tunneled long-term peritoneal catheter].
    Semmo N; Seuthe B; Thimme R; Graf KJ
    Dtsch Med Wochenschr; 2009 Oct; 134(41):2073-6. PubMed ID: 19802769
    [No Abstract]   [Full Text] [Related]  

  • 12. Paracentesis in ovarian cancer: a study of the physiology during free drainage of ascites.
    Decruze SB; Macdonald R; Smith G; Herod JJ
    J Palliat Med; 2010 Mar; 13(3):251-4. PubMed ID: 19929225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Percutaneous placement of peritoneal port-catheter in patients with malignant ascites.
    Ozkan O; Akinci D; Gocmen R; Cil B; Ozmen M; Akhan O
    Cardiovasc Intervent Radiol; 2007; 30(2):232-6. PubMed ID: 17206391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ability of existing questionnaires to measure symptom change after paracentesis for symptomatic ascites.
    Easson AM; Bezjak A; Ross S; Wright JG
    Ann Surg Oncol; 2007 Aug; 14(8):2348-57. PubMed ID: 17505860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attitudes to chemotherapy in patients with ovarian cancer.
    Penson RT; Dignan F; Seiden MV; Lee H; Gallagher CJ; Matulonis UA; Olson K; Gibbens I; Gore ME
    Gynecol Oncol; 2004 Aug; 94(2):427-35. PubMed ID: 15297184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current and future options in the treatment of malignant ascites in ovarian cancer.
    Woopen H; Sehouli J
    Anticancer Res; 2009 Aug; 29(8):3353-9. PubMed ID: 19661355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Palliative radiation therapy of symptomatic recurrent bladder cancer.
    Yi SK; Yoder M; Zaner K; Hirsch AE
    Pain Physician; 2007 Mar; 10(2):285-90. PubMed ID: 17387350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Key problems to diagnosis and treatment of epithelial ovarian cancer].
    Shen K; Lang JH
    Zhonghua Fu Chan Ke Za Zhi; 2003 Feb; 38(2):65-8. PubMed ID: 12833894
    [No Abstract]   [Full Text] [Related]  

  • 19. [Current surgical management in ovarian cancer recurrences].
    Tinelli FG; Tinelli A; Campagnutta E; Kobal B; Rakar S; Manca C; Tinelli R; Perrone A
    Minerva Ginecol; 2004 Oct; 56(5):457-67. PubMed ID: 15531862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Palliative Care and Symptom Management for Women with Advanced Ovarian Cancer.
    Miller D; Nevadunsky N
    Hematol Oncol Clin North Am; 2018 Dec; 32(6):1087-1102. PubMed ID: 30390762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.